Contact
Please use this form to send email to PR contact of this press release:
ApeX Therapeutics Announces FDA Acceptance of IND to Evaluate the Tolerability and Anti-Tumor Effects of APX3330
TO:
Please use this form to send email to PR contact of this press release:
ApeX Therapeutics Announces FDA Acceptance of IND to Evaluate the Tolerability and Anti-Tumor Effects of APX3330
TO: